December 2021

SirVir to present at the Biotech showcase in San Francisco (January 10-12 , 2021)

March 2021

Aposense and Bioasis Technologies Inc. Enter into a Research Collaboration

February 2021

SirVir Ltd., an Aposense subsidiary in the field of respiratory viral infections announce the fulfillment of a $14M milestone investment

June 2020

Aposense enters into an out-licensing agreement with Processa Pharmaceuticals

April 2020

SirVir obtained positive results in pre-clinical experiment against COVID-19

January 2020

Prof. Roger Kornberg mentions SirVir’s breakthrough results and applicability of the platform in an interview for Ynet